AA
TMO icon

Advisory Alpha’s Thermo Fisher Scientific TMO Stock Holding History

Advisory Alpha’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602K Sell
1,200
-47
-4% -$22.6K 0.01% 328
2026
Q1 		$613K Buy
1,247
+272
+28% +$148K 0.02% 285
2025
Q4 		$565K Buy
975
+34
+4% +$19.2K 0.02% 278
2025
Q3 		$494K Sell
941
-133
-12% -$61.9K 0.01% 295
2025
Q2 		$436K Sell
1,074
-557
-34% -$233K 0.01% 290
2025
Q1 		$812K Buy
1,631
+199
+14% +$108K 0.03% 183
2024
Q4 		$745K Buy
1,432
+159
+12% +$87.4K 0.03% 181
2024
Q3 		$788K Buy
1,273
+224
+21% +$133K 0.03% 171
2024
Q2 		$580K Buy
1,049
+270
+35% +$155K 0.02% 193
2024
Q1 		$453K Buy
779
+340
+77% +$191K 0.02% 225
2023
Q4 		$233K Buy
+439
New +$212K 0.01% 307
2020
Q4 		– Sell
-104
Closed -$47K – 595
2020
Q3 		$47K Buy
+104
New +$43K 0.01% 216
2020
Q2 		– Sell
-50
Closed -$16K – 564
2020
Q1 		$16K Hold
50
– – ﹤0.01% 342
2019
Q4 		$16.6K Buy
50
+4
+9% +$1.21K ﹤0.01% 428
2019
Q3 		$12.7K Buy
+46
New +$13.2K ﹤0.01% 425
2019
Q2 		– Sell
-13
Closed -$3.5K – 588
2019
Q1 		$3.5K Buy
+13
New +$3.23K ﹤0.01% 500

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Advisory Alpha's TMO Position: Q2 2026 in Review

Advisory Alpha reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, selling an estimated $22.6K and leaving 1,200 shares worth $602K. The position accounts for 0.01% of the portfolio, ranked #328.

Advisory Alpha first reported a position in TMO in Q1 2019 and has held it in 16 quarters since. The position peaked at $812K in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Advisory Alpha held 1,200 shares of Thermo Fisher Scientific worth $602K as of Q2 2026.
  • Advisory Alpha sold 47 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.6K.
  • Thermo Fisher Scientific made up 0.01% of Advisory Alpha's portfolio in Q2 2026, its #328 holding.
  • Advisory Alpha first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 16 quarters since.
  • Advisory Alpha's Thermo Fisher Scientific position peaked at $812K in Q1 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.